Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00163111 | A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. | PHASE3 | COMPLETED | 412 | — | — | Sep 1, 1998 | May 1, 2003 | Apr 26, 2011 | - | — |
| Name | Type | Description |
|---|---|---|
| VFEND® I.V., Oral | DRUG | - |
| Conventional amphotericin B | DRUG | - |
| Diflucan IV, oral | DRUG | - |
Inclusion Criteria: * Patients with candidemia Exclusion Criteria: * Neutropenia